Skip to main content
Home logo

User account menu

Log inSearch

Main navigation

  • Home
  • Data Sources
  • Studies
  • Institutions
  • Networks
  • What's new
  • Support
  1. Home

Hidroxicloroquine and cloroquine safety profile in patients with SARS-COV-2 infection (COVID-19) (SEHISACoV-2)

02/06/2020
15/09/2021
EU PAS number:
EUPAS35528
Study
Planned
Subscribe
Download as PDF

Secondary tabs

Administrative detailsMethodological aspectsData managementResources

Page content

  • Documents
  • Publications
  • ENCePP Seal
Documents
Study protocol
Study results
Study report
Other information
Publications
Study publications
Chatre, C., Roubille, F., Vernhet, H. et al. Cardiac Complications Attributed t…
Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic revie…
White NJ. Cardiotoxicity of antimalarial drugs. The Lancet infectious diseases…
Haeusler, I.L., Chan, X.H.S., Guérin, P.J. et al. The arrhythmogenic cardiotoxi…
Tönnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy–a review of the…

Share this page

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Privacy policy
Cookies
Legal notice

Contact

Contact us